Cargando…
Mesoporous Silica Nanoparticles Enhance the Anticancer Efficacy of Platinum(IV)-Phenolate Conjugates in Breast Cancer Cell Lines
The main reasons for the limited clinical efficacy of the platinum(II)-based agent cisplatin include drug resistance and significant side effects. Due to their better stability, as well as the possibility to introduce biologically active ligands in their axial positions constructing multifunctional...
Autores principales: | Predarska, Ivana, Saoud, Mohamad, Drača, Dijana, Morgan, Ibrahim, Komazec, Teodora, Eichhorn, Thomas, Mihajlović, Ekatarina, Dunđerović, Duško, Mijatović, Sanja, Maksimović-Ivanić, Danijela, Hey-Hawkins, Evamarie, Kaluđerović, Goran N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9659259/ https://www.ncbi.nlm.nih.gov/pubmed/36364539 http://dx.doi.org/10.3390/nano12213767 |
Ejemplares similares
-
Ruthenacarborane and Quinoline: A Promising Combination for the Treatment of Brain Tumors
por: Drača, Dijana, et al.
Publicado: (2021) -
Drug Delivery System for Emodin Based on Mesoporous Silica SBA-15
por: Krajnović, Tamara, et al.
Publicado: (2018) -
Quinoline‐Conjugated Ruthenacarboranes: Toward Hybrid Drugs with a Dual Mode of Action
por: Gozzi, Marta, et al.
Publicado: (2019) -
Metallodrugs against Breast Cancer: Combining the Tamoxifen Vector with Platinum(II) and Palladium(II) Complexes
por: Kazimir, Aleksandr, et al.
Publicado: (2023) -
Correction: Kazimir et al. Metallodrugs against Breast Cancer: Combining the Tamoxifen Vector with Platinum(II) and Palladium(II) Complexes. Pharmaceutics 2023, 15, 682
por: Kazimir, Aleksandr, et al.
Publicado: (2023)